Cigna Group (NYSE:CI) Rating Lowered to Hold at Wall Street Zen

Cigna Group (NYSE:CI) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Several other equities analysts also recently commented on CI. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price objective for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Mizuho increased their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Barclays boosted their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Piper Sandler lowered their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Finally, Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Fifteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $337.10.

Cigna Group Stock Performance

NYSE:CI opened at $280.51 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market cap of $74.12 billion, a PE ratio of 11.61, a price-to-earnings-growth ratio of 0.96 and a beta of 0.31. The business has a 50 day moving average price of $283.31 and a 200-day moving average price of $280.77.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Evercore Wealth Management LLC increased its stake in Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after acquiring an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC raised its position in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after purchasing an additional 36 shares during the period. Independence Bank of Kentucky lifted its stake in shares of Cigna Group by 2.6% in the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after purchasing an additional 37 shares during the last quarter. West Family Investments Inc. lifted its stake in shares of Cigna Group by 4.2% in the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock valued at $253,000 after purchasing an additional 37 shares during the last quarter. Finally, IHT Wealth Management LLC grew its holdings in shares of Cigna Group by 2.5% during the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after purchasing an additional 38 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.